The Sterile Drug Manufacturing GMP Facility is an advanced GMP (Good Manufacturing Practice) certified facility situated within the esteemed Healthcare Technology Accelerator Facility (HTAF) team in the Institute of Regeneration and Repair at the University of Edinburgh BioQuarter. This cutting-edge facility specialises in the production of Investigational Medicinal Products MIA (IMP) and has secured certification from the Medicines and Healthcare Products Regulatory Agency (MHRA). The Facility excels in aseptic sterile fills, tailored for clinical trials, while also accommodating commercial contracts. The Facility is currently undergoing a transformative relocation to a state-of-the-art facility that is three times the size of its previous site. This strategic move is driven by an ambitious objective to significantly increase production capacity and capabilities. The new facility is currently in the validation phase, ensuring it meets the highest standards of quality and regulatory compliance. Once validation is complete, the facility will promptly submit applications for Investigational Medicinal Products (IMPs) to the MHRA. This transition presents an exceptional opportunity for potential collaborations and partnerships, as we actively seek applications for customized process requirements. With expanded capacity and cutting-edge infrastructure, the facility is well-prepared to incorporate new processes into its production calendar. SFU's relocation and expansion mark a pivotal moment in their journey, underscoring their dedication to advancing pharmaceutical manufacturing and offering innovative solutions to address the evolving needs of the industry. This article was published on 2022-09-29
